Robinson Chandler bought MNPR
December 2, 2025 · Form 4 insider transaction
Robinson Chandler bought 49,133 shares of Monopar Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 6 days after the transaction.
Direction
Acquired (buy-side)
Shares
49,133
Price
$0.00
Total value
N/A
InsiderRobinson Chandler
Role—
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateDecember 2, 2025
Filing dateDecember 8, 2025
Shares owned after121,732
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
RSUs vest 6/48ths on June 30, 2026, and 3/48ths per quarter thereafter.